ArticleBMC cancer2022

Incidence and associated factors of cetuximab-induced hypersensitivity infusion reactions in 1392 cancer patients treated in four French areas: a possible association with Lyme disease?

M Dupont et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.